Deciphex

Glasnevin, Ireland

Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.

$32.2M raised

Jan 2025

Series C

Top Investors

NovartisEnterprise IrelandGI PartnersClaret Capital PartnersCharles River Laboratories International

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Deciphex raised?

Deciphex has raised $32.2M in total funding. The most recent round was Series C. The last funding was announced in January 2025.

Who are Deciphex's investors?

Deciphex's investors include Novartis, Enterprise Ireland, GI Partners, Claret Capital Partners, Charles River Laboratories International.

Where is Deciphex headquartered?

Deciphex is headquartered in Glasnevin, Ireland.

What does Deciphex do?

Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.

What stage is Deciphex at?

Deciphex is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 7, 2025.

MLA

"Deciphex — Funding & Investors." VCBacked, January 7, 2025, https://www.vcbacked.co/company/deciphex. Accessed June 4, 2026.

APA

VCBacked. (2025). Deciphex — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/deciphex

Wikipedia (cite web)

{{cite web |title=Deciphex — Funding & Investors |url=https://www.vcbacked.co/company/deciphex |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 7, 2025.